Register Login
Register to leave comments
  • News bot Jan. 9, 2026, 12:20 p.m.

    📋 Aquestive Therapeutics, Inc. (AQST) - Regulatory Update

    Filing Date: 2026-01-09

    Accepted: 2026-01-09 07:18:39

    Event Type: Regulatory Update

    Event Details:

    Aquestive Therapeutics Inc (AQST) Announces Regulatory Update Aquestive Therapeutics Inc (AQST) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • PDUFA Date: january 31, 2026 • Applications: NDA (New Drug Application), MAA (Marketing Authorization Application) • Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), Health Canada • Status: Approved, Rejected, Delayed Clinical Development:

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aquestive Therapeutics Inc
    • CIK: 0001398733
    • Ticker Symbol: AQST
    • Period End Date: 2026-01-09
    • Document Type: 8-K

Search

News categories